BNOEF Stock Performance, Insider Transaction and News

BNOEF - BIONOMICS LTD

Market Cap	23.50M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-24.91M	Forward P/E	-	EPS next Y	-	50D Avg Chg	-10.00%
Sales	6.02M	PEG	-	EPS past 5Y	-	200D Avg Chg	-36.00%
Dividend	N/A	Price/Book	0.50	EPS next 5Y	-	52W High Chg	-71.00%
Recommedations	-	Quick Ratio	8.43	Shares Outstanding	1.47B	52W Low Chg	60.00%
Insider Own	7.19%	ROA	-20.98%	Shares Float	0.98B	Beta	1.84
Inst Own	29.33%	ROE	-46.14%	Shares Shorted/Prior	-/-	Price	0.02
Gross Margin	-229.04%	Profit Margin	-	Avg. Volume	184,265	Target Price	-
Oper. Margin	-346.16%	Earnings Date	-	Volume	15,000	Change	0.00%

Healthcare | Biotechnology | Australia

About BIONOMICS LTD

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co., Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

BNOEF Chatroom

cctranscripts Posted - 3 months ago

Annual and transition report of foreign private issuers [Sections 13 or 15(d)] https://www.conferencecalltranscripts.org/summary/?id=12871283 $BNOEF

cctranscripts Posted - 3 months ago

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12841985 $BNOEF

cctranscripts Posted - 11/30/23

Bionomics: Results Of Annual General Meeting https://www.conferencecalltranscripts.org/summary/?id=12751765 $BNOEF

cctranscripts Posted - 11/28/23

Bionomics Announces Retirement Of Board Member https://www.conferencecalltranscripts.org/summary/?id=12743228 $BNOEF

cctranscripts Posted - 5 months ago

Bionomics: Acn 075 582 740 https://www.conferencecalltranscripts.org/summary/?id=12671380 $BNOEF

cctranscripts Posted - 10/30/23

Weston Nichols just provided an update on share ownership of Bionomics Ltd. https://www.conferencecalltranscripts.org/summary/?id=12654411 $BNOEF

cctranscripts Posted - 6 months ago

Bionomics Ltd. just filed its Annual and transition report of foreign http://www.sec.gov/Archives/edgar/data/1191070/000095017023053873/0000950170-23-053873-index.htm $BNOEF

cctranscripts Posted - 6 months ago

Bionomics Announces Successful End-Of-Phase 2 Meeting With The Fda And Solidifies Plans To Init https://www.conferencecalltranscripts.org/summary/?id=12616352 $BNOEF

cctranscripts Posted - 6 months ago

Kevin Tang just provided an update on share ownership of Bionomics Ltd. https://www.conferencecalltranscripts.org/summary/?id=12604809 $BNOEF

cctranscripts Posted - 09/29/23

Steven A. Cohen just provided an update on share ownership of Bionomics Ltd. https://www.conferencecalltranscripts.org/summary/?id=12580617 $BNOEF

cctranscripts Posted - 09/29/23

Bionomics: Abn 55 075 582 740 Statutory Accounts https://www.conferencecalltranscripts.org/summary/?id=12578386 $BNOEF

cctranscripts Posted - 09/28/23

Bionomics Announces Positive Topline Results From The Phase 2B Attune Clinical Trial Of Bnc210 https://www.conferencecalltranscripts.org/summary/?id=12573942 $BNOEF

ArsenalFC23 Posted - 7 months ago

$BNOEF $BNOX If the PtSD trail hasn't failed I would be astound. Looks like someone already knows the outcome of the trail. When the SP decreases until readouts that's most likely a hint of a failure and a leak too (just look at SEEL). Plus Bionomics and Bnc210 has has a history of trail failures (PTSD and SAD trails).

risenhoover Posted - 8 months ago

$BNOEF BNOEF / Bionomics Ltd. Price Target Updated https://fintel.io/sfo/us/bnoef?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

cctranscripts Posted - 07/31/23

Bionomics: Abn 53 075 582 740 ASX ANNOUNCEMENT https://www.conferencecalltranscripts.org/summary/?id=12401715 $BNOEF

cctranscripts Posted - 07/28/23

Bionomics: An Ads Conversion Facility Election Form https://www.conferencecalltranscripts.org/summary/?id=12395834 $BNOEF